Please assess the completion status of the following clinical trial:

Trial Title: LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Clinical Criteria~* Male or non-pregnant female ≥18 years of age.~* Rutherford Clinical Category 2-5~* Patient is willing to provide informed consent and comply with the required follow up visits, testing schedule, and medication regimen Angiographic Criteria~* A single de novo or restenotic atherosclerotic lesion \>70% in the SFA or popliteal artery that is ≥4 cm and ≤15 cm in total length.~* Reference vessel diameter ≥4 mm and ≤ 6mm~* Successful wire crossing of lesion~* A patent inflow artery free from significant lesion (\>50% stenosis) as confirmed by angiography (treatment of target lesion acceptable after successful treatment of inflow artery lesions)~Exclusion Criteria:~* Pregnant or planning on becoming pregnant in \< 2yrs~* Live expectancy of \<2 years~* Patient actively participating in another investigational device or drug study~* History of hemorrhagic stroke within 3 months~* Previous or planned surgical or interventional procedure within 30 days of index procedure~* Chronic renal insufficiency with creatinine \>2.5 mg/L~* Prior surgery of the target lesion~* Inability to take required study medications~* Anticipated use of IIb/IIIa inhibitor prior to randomization~* Lesion length is \<4 cm or \>15 cm or there is no normal proximal arterial segment in which duplex ultrasound velocity ratios can be measured~* Known inadequate distal outflow~* Significant inflow disease~* Acute or sub-acute thrombus in target vessel~* Severe lesion calcification~* Acute vessel occlusion or sudden symptom onset~* Use of adjunctive therapies (i.e. laser, atherectomy, cryoplasty, scoring/cutting balloon, etc.)~* Prior participation in the current study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lutonix Catheter (Type: EXPERIMENTAL): Paclitaxel coated Balloon Catheter
- Standard uncoated Balloon Angioplasty Catheter (Type: ACTIVE_COMPARATOR): uncoated angioplasty balloon

Based on this trial design, predict the completion outcome and termination type (if applicable).